Infectious Disease Rapid Diagnostic Testing Market Trend - Increasing Incidence of Infectious Diseases Across The Globe
07 Jun 2022
Antibody
Increasing incidence of infectious diseases across the globe, rapid advancement in point-of-care testing devices, and rising affordability of clinical diagnostics are some key factors expected to drive Infectious Disease Rapid Diagnostic Testing market revenue growth.
According to Emergen Research, the global infectious disease rapid diagnostic testing market size was USD 27.89 billion in 2021 and is expected to reach USD 51.01 Billion in 2030 and register a revenue CAGR of 7% during the forecast period, 2020-2027.
Market Dynamics:
Prevalence of infectious diseases has rapidly increased across the globe over the recent past due to rapid spread of infectious pathogens through a rapidly rising global population. Most common infectious diseases are lower respiratory infections, diarrheal diseases, viral hepatitis, and parasitic diseases spread through consumption of raw fishes and ethnic food. Increasing need to prevent the spread of infectious diseases, growing awareness among individuals for rapid diagnosis and treatment, increasing trend of point-of-care diagnostic testing, and introduction of novel infectious diseases diagnostic testing kits are some key factors expected to drive market revenue growth over the forecast period.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @
Rapid diagnostic testing, in context to infectious diseases, includes lateral flow, immunochromatographic tests that are used to detect certain infections. Rapid diagnostic tests (RDTs) for infectious diseases have emerged as a promising tool to improve patient care, make timely optimization of antimicrobial use, and to prevent infection in the emergency department settings. Rapid diagnostic tests for infectious diseases have been widely implemented in laboratories and emergency rooms to expand the diagnosis of infection and facilitate antimicrobial stewardship in the emergency departments wherein rapid clinical decisions are imperative to prevent overcrowding and time pressure. Over the recent years, with recent advancements in technology, numerous rapid diagnostic testing kits have been introduced. Emergence of COVID-19 pandemic has further boosted demand for rapid test kits and this is expected to further drive market revenue growth over the coming years. In addition, stringent regulations regarding approval and high costs of certain diagnostic products are expected to restrain revenue growth of the market to a certain extent going ahead.
COVID-19 Impact Analysis:
Social distancing and restrictions severely disrupted businesses and operations
Lockdowns caused disruptions in transportation and logistics
Impacted manufacturing activities and mining operations globally
Took a toll on economy of various countries
Caused sudden and drastic downturn in economic activity
Disrupted agriculture, fisheries, dairy, and other sectors
Caused loss of employment and financial crisis
Supply impacts were further compounded owing to reduced disposable income
Emergence of variants continue to cause concerns and impact normal routines
Polymerase Chain Reaction Segment to Account for Largest Revenue Share:
Polymerase chain reaction segment is expected to account for largest revenue share in the global market over the forecast period attributable to increasing adoption of PCR technique in diagnostics due to its accuracy and efficacy in detecting toxins and infectious disease causing agents, introduced of new and improved PCR techniques, and availability of PCR-based rapid diagnostic test kits.
Browse Full Report Description + Research Methodology + Table of Content + Infographics@
Hepatitis Segment to Dominate Other Disease Segments:
Hepatitis segment is expected to dominate other disease segment in terms of revenue share over the forecast period attributable to rising incidence of hepatitis B across the globe, growing demand for rapid diagnostic test kits for the disease, and increasing need to prevent the spread of the disease.
North America to Lead in Terms of Revenue Share:
North America is expected to account for a significantly large revenue share in the global market over the forecast period attributable to increasing prevalence of infectious diseases, rapid technological advancements in clinical diagnostics, presence of established healthcare infrastructure, favorable reimbursement policies, availability of affordable point-of-care diagnostic test kits, and increasing network of hospitals and clinics in the region.
Major Companies in the Market Include:
Abbott Laboratories
Danaher Corporation
F. Hoffmann-La Roche Ltd.
Thermo Fisher Scientific Corporation
BioMérieux SA
BD (Becton, Dickinson and Company)
Siemens Healthineers AG
PerkinElmer Inc.
Bio-Rad Laboratories, Inc.
Sysmex Corporation
Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @
For the purpose of this report, Emergen Research has segmented the global infectious disease rapid diagnostic testing market on the basis of product & service, technology, disease, end-use, and region:
Product & Service Outlook (Revenue, USD Billion; 2019–2030)
Reagent & Kits
Instruments
Data Management Software
Service
Technology Outlook (Revenue, USD Billion; 2019–2030)
Immunoassay
Enzyme-linked Immunosorbent Assay (ELISA)
Enzyme-linked Immunospot Assay (ELISpot)
Polymerize Chain Reaction (PCR)
Isothermal Nucleic Acid Amplification Technology (INAAT)
DNA Microarray
Clinical Microbiology
Other Technologies
Disease Outlook (Revenue, USD Billion; 2019–2030)
Hepatitis
Influenza
HIV/AIDS
HPV
CT/NG
Tuberculosis
HAIs
COVID-19
Others
End-Use Outlook (Revenue, USD Billion; 2019–2030)
Hospital & Clinical Laboratories
Diagnostic Center
Academic & Research Institutions
Others
Regional Outlook (Revenue, USD Billion; 2019–2030)
North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
BENELUX
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Rest of APAC
Latin America
Brazil
Rest of LATAM
Middle East & Africa
Saudi Arabia
U.A.E.
South Africa
Turkey
Rest of MEA
Looking to Purchase Reports in Bundle [Schedule a Call with An Analyst]@
Read Latest Reports Published by Emergen Research:
High-Performance Computing Market
Industrial Packaging Market
Interventional Oncology Devices Market
Blood-Brain Barrier Market
Antibody Services Market
Air Quality Monitoring System Market
Autoclaved Aerated Concrete Market
Cloud TV Market
Cash Flow Market
Digital Twin Market
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trend’s existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web:
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights:
Explore Our Custom Intelligence services | Growth Consulting Services
Press Release Available @
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.